Summit Therapeutics plc (SMMT) Slipped -9.13% or -0.21 To Price $2.09 On Friday


Summit Therapeutics plc (SMMT) slipped -9.13% or -0.21 to $2.09. It is approximately 28967 shares traded, which is 28.6% compare to the average total volume 101269. The market cap of SMMT is $67.04 million. The year to date change is 82.54%. The 52 week price range is from $1.1 to $14.29. Price of SMMT have changed 71.19% during last week. It have changed 64.29% over last month, 85.48% over last 3 months, 12.20% over last 6 months and -81.22% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SMMT is 1.41. It is -32.54% below current price. The 200-day Moving Averages for SMMT is 3.77. It is 80.38% above current price. The 52-week High is 14.29. It is 583.73% from the current price. The 52-week Low is 1.1. It is -47.37% from current price.

There are some statistics of SMMT. It is has market cap $67.04 million. The share outstanding is 32.08 million. The average volume is 101269. The percent of top 15 Institution holding is 9.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SMMT is 65.53%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SMMT is 30.93%.


Tags:

Share this post